Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-22-026716
Filing Date
2022-02-24
Accepted
2022-02-24 17:09:35
Documents
6
Effectiveness Date
2022-02-24

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm227309d1_s3asr.htm S-3ASR 232530
2 EXHIBIT 4.8 tm227309d1_ex4-8.htm EX-4.8 312151
3 EXHIBIT 5.1 tm227309d1_ex5-1.htm EX-5.1 30662
4 EXHIBIT 23.2 tm227309d1_ex23-2.htm EX-23.2 2568
5 EX-FILING FEES tm227309d1_ex-filingfees.htm EX-FILING FEES 38371
6 GRAPHIC tm227309d1ex5-1img_001.jpg GRAPHIC 4812
  Complete submission text file 0001104659-22-026716.txt   624152
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-262987 | Film No.: 22672457
SIC: 2834 Pharmaceutical Preparations